---
title: "Psych News Alert: Gabapentin Found to Work Best for Those With Severe Alcohol Withdrawal Syndrome"
description: Gabapentin is effective at reducing heavy drinking and promoting abstinence among people with alcohol use disorder (AUD), especially thos...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/alcohol_iStock-471076453-2.jpg
---

 3/9/20 12:00 AM

# Gabapentin Found to Work Best for Those With Severe Alcohol Withdrawal Syndrome

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2020/03/gabapentin-found-to-work-best-for-those.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2020/03/gabapentin-found-to-work-best-for-those.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2020/03/gabapentin-found-to-work-best-for-those.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2020/03/gabapentin-found-to-work-best-for-those.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2020/03/gabapentin-found-to-work-best-for-those.html)

| ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/alcohol_iStock-471076453-3.jpg?width=200&height=128&name=alcohol_iStock-471076453-3.jpg) |  |
| --- | --- |

Gabapentin is effective at reducing heavy drinking and promoting abstinence among people with alcohol use disorder (AUD), especially those with strong withdrawal symptoms, reports a [study](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2762700) published today in *JAMA Internal Medicine*.

Previous studies suggest that gabapentin can help reduce short-term symptoms of alcohol withdrawal syndrome, which can include irritability, anxiety, sweating, and insomnia. The research on gabapentin’s ability to promote long-term reductions in drinking has been mixed, however.

Raymond Anton, M.D., and colleagues at the Medical University of South Carolina enrolled 96 adults who met the *DSM-5* diagnosis for AUD, including alcohol withdrawal. After three days of alcohol abstinence, the participants were randomly assigned to receive either gabapentin (starting at 300 mg/day and titrated up to 1,200 mg/day) or placebo pills for 16 weeks. Participants also received nine medical management sessions, consisting of 15- to 20-minute appointments with a medical professional during which they were assessed on daily drinking since their last visit.

At the end of the study, 27% of the participants taking gabapentin reported no heavy drinking days (defined as consuming five or more drinks a day for men, four or more for women) compared with 9% of the participants taking placebo. In addition, 21% of the gabapentin participants reported total abstinence during the study, compared with 4% of the participants in the placebo group. Reduced drinking was especially prominent among participants who had higher alcohol withdrawal scores at baseline. Participants with low withdrawal scores at baseline had similar outcomes regardless of whether they took gabapentin or placebo.

“The weight of the evidence now suggests that gabapentin might be most efficacious after the initiation of abstinence to sustain it and that it might work best in those with a history of more severe alcohol withdrawal symptoms,” Anton and colleagues wrote. “Armed with this knowledge, clinicians may have another alternative when choosing a medication to treat AUD and thereby encourage more patient participation in treatment with enhanced expectation of success.”

To read more on this topic, see the *Psychiatric News* article “[APA Releases Practice Guideline for AUD Pharmacotherapy](https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2018.pp1b4)” and [APA’s Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder](https://psychiatryonline.org/doi/book/10.1176/appi.books.9781615371969).

(photo: iStock/blueclue)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/Twitter_Bird-Jun-24-2025-07-51-16-8970-PM.png?width=21&height=17&name=Twitter_Bird-Jun-24-2025-07-51-16-8970-PM.png)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/Twitter_Bird-Jun-24-2025-07-51-16-8970-PM.png) 

**[Follow *Psychiatric News* on Twitter!](https://twitter.com/PsychiatricNews)

And check out the new [*Psychiatric News Brief*](http://alexapn.apapublishing.libsynpro.com/) on Alexa-enabled devices.**

[JAMA Internal Medicine](https://alert.psychnews.org/tag/jama-internal-medicine), [alcohol](https://alert.psychnews.org/tag/alcohol), [alcohol use disorder](https://alert.psychnews.org/tag/alcohol-use-disorder), [psychopharmacology](https://alert.psychnews.org/tag/psychopharmacology), [alcohol withdrawal](https://alert.psychnews.org/tag/alcohol-withdrawal), [abstinence](https://alert.psychnews.org/tag/abstinence), [clinical trial](https://alert.psychnews.org/tag/clinical-trial), [gabapentin](https://alert.psychnews.org/tag/gabapentin)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/no_alcohol_iStock-850996882-2.jpg?height=200&name=no_alcohol_iStock-850996882-2.jpg) ](https://alert.psychnews.org/2025/04/oral-and-injectable-naltrexone-found.html)

[naltrexone](https://alert.psychnews.org/tag/naltrexone), [alcohol](https://alert.psychnews.org/tag/alcohol), [AUD](https://alert.psychnews.org/tag/aud), [alcohol use disorder](https://alert.psychnews.org/tag/alcohol-use-disorder), [heavy drinking](https://alert.psychnews.org/tag/heavy-drinking), [hospitalization](https://alert.psychnews.org/tag/hospitalization), [extended release](https://alert.psychnews.org/tag/extended-release)

## [Oral and Injectable Naltrexone Found Equally Effective in Hospitalized Patients With AUD](https://alert.psychnews.org/2025/04/oral-and-injectable-naltrexone-found.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 4/24/25 12:00 AM

[ Read more ](https://alert.psychnews.org/2025/04/oral-and-injectable-naltrexone-found.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/doctor_patient_iStock-1070356964-Jun-24-2025-10-36-29-6118-PM.jpg?height=200&name=doctor_patient_iStock-1070356964-Jun-24-2025-10-36-29-6118-PM.jpg) ](https://alert.psychnews.org/2019/09/patients-with-severe-alcohol-withdrawal.html)

[alcohol](https://alert.psychnews.org/tag/alcohol), [hallucinations](https://alert.psychnews.org/tag/hallucinations), [Mladen Nisavic](https://alert.psychnews.org/tag/mladen-nisavic), [alcohol withdrawal](https://alert.psychnews.org/tag/alcohol-withdrawal), [seizures](https://alert.psychnews.org/tag/seizures), [delirium](https://alert.psychnews.org/tag/delirium), [phenobarbital](https://alert.psychnews.org/tag/phenobarbital), [benzodiazepines](https://alert.psychnews.org/tag/benzodiazepines), [Psychosomatics](https://alert.psychnews.org/tag/psychosomatics)

## [Patients With Severe Alcohol Withdrawal May Benefit From Phenobarbital, Study Suggests](https://alert.psychnews.org/2019/09/patients-with-severe-alcohol-withdrawal.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/9/19 12:00 AM

Phenobarbital, a long-acting barbiturate, may be an effective alternative to benzodiazepines for...

[ Read more ](https://alert.psychnews.org/2019/09/patients-with-severe-alcohol-withdrawal.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/therapist_patient_iStock-1058833158-Jun-24-2025-04-35-20-3217-PM.jpg?height=200&name=therapist_patient_iStock-1058833158-Jun-24-2025-04-35-20-3217-PM.jpg) ](https://alert.psychnews.org/2020/09/apa-releases-updated-practice-guideline.html)

[clozapine](https://alert.psychnews.org/tag/clozapine), [psychosocial interventions](https://alert.psychnews.org/tag/psychosocial-interventions), [patient preference](https://alert.psychnews.org/tag/patient-preference), [Institute of Medicine](https://alert.psychnews.org/tag/institute-of-medicine), [evaluation](https://alert.psychnews.org/tag/evaluation), [pharmacotherapy](https://alert.psychnews.org/tag/pharmacotherapy), [APA Practice Guideline for the Treatment of Patien](https://alert.psychnews.org/tag/apa-practice-guideline-for-the-treatment-of-patien)

## [APA Releases Updated Practice Guideline for Treatment of Patients With Schizophrenia](https://alert.psychnews.org/2020/09/apa-releases-updated-practice-guideline.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/2/20 12:00 AM

Yesterday, APA released a new evidence-based guideline on treating patients with schizophrenia. The...

[ Read more ](https://alert.psychnews.org/2020/09/apa-releases-updated-practice-guideline.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T19:52:22.833Z",
  "datePublished" : "2020-03-09T04:00:00.000Z",
  "headline" : "Psych News Alert: Gabapentin Found to Work Best for Those With Severe Alcohol Withdrawal Syndrome",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/alcohol_iStock-471076453-2.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2020/03/gabapentin-found-to-work-best-for-those.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```